Microbial DNA in Patient Blood May be Tell-Tale Sign of Cancer
March 11, 2020
From a simple blood draw, microbial DNA may reveal who has cancer and which type, even at early stages.
Your search for “Diagnostics” returned 372 results
NanoEngineering Department at UC San Diego Receives $2.1M Gift from the Aiiso Yufeng Li Family
February 21, 2024
Nanoengineer, entrepreneur and philanthropist Aiiso Yufeng Li (Jeff), and his family have pledged a $2.1M gift to the UC San Diego Jacobs School of Engineering. The gift will support research, education and student activities in the Department of NanoEngineering at the Jacobs School of Engineering.
Researchers Identify Characteristic Chemical Signature for Chronic Fatigue Syndrome
August 29, 2016
Chronic fatigue syndrome (CFS) is a mysterious and maddening condition, with no cure or known cause. But researchers at the University of California San Diego School of Medicine, using a variety of techniques to identify and assess targeted metabolites in blood plasma, have identified a characteristic chemical signature for the…
UC San Diego Launches New Nonalcoholic Fatty Liver Disease Research Center
February 8, 2016
Roughly one-quarter of all Americans – an estimated 100 million adults and children – have nonalcoholic fatty liver disease (NAFLD), a chronic condition that can lead to cirrhosis, liver cancer and liver failure. Combining a diverse array of basic science, biomarkers, imaging and clinical efforts, University of California, San Diego…
First-Ever Mycobiome Atlas Describes Associations between Cancers and Fungi
September 29, 2022
An international team of scientists, co-led by researchers at the University of California San Diego School of Medicine, has created the first pan-cancer mycobiome atlas—a survey of 35 types of cancer and their associated fungi.
Cultural Heritage Center at UC San Diego Reports Progress in 2012
November 26, 2012
…UC San Diego center’s for engineering in cultural heritage diagnostics.
Radical Surgery Saves Life of Young Mom, California First
January 5, 2012
A team led by Alan Hemming, MD, transplant surgeon at UC San Diego Health System, has successfully performed the west coast’s first ex-vivo liver resection, a radical procedure to completely remove and reconstruct a diseased liver and re-implant it without any tumors.
Monoclonal Antibody Targets, Kills Leukemia Cells
March 25, 2013
Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.
The mystartupXX Accelerator Program Wins $50,000 Award from the SBA
September 1, 2016
For the third year in a row, the mystartupXX accelerator program, a UC San Diego-wide program started as a collaboration of the California Institute for Innovation and Development at the Rady School of Management at UC San Diego and the UC San Diego Jacobs School of Engineering in 2012, has…
Researchers Identify Potential Diagnostic Test for Kawasaki Disease
August 6, 2018
…in whole blood. The finding could lead to a diagnostic blood test to distinguish KD from other infectious and inflammatory conditions.
